ATH 33.3% 0.4¢ alterity therapeutics limited

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-4

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 2,840 Posts.
    lightbulb Created with Sketch. 995
    It is time to commercialize the PBT2 license in treating antibiotic-resistant infections. ATH needs this to happen to survive. PBT2 is needed around the world by patients with these deadly infections. ATH has had almost 3 years to do this. Now it is the time!
 
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.